PORTFOLIO
Portfolio
-
Galux -
NOVELTY NOBILITY -
Noul -
NuVi labs -
Neuracle Genetics -
NeuroXT -
DAAN Biotherapeutics -
WSG -
DeepCardio -
LaSemilla -
LiveCell Instrument -
RevoSketch -
ROKIT HEALTHCARE -
Regen Innopharm -
Lynk Solutec -
MasterMeditech -
MEDIOGEN -
Meditrix -
Medipixel -
MirimGENE -
BIORCHESTRA -
ViGenCell -
CELLAPEUTICS BIO -
CELLEMEDY -
SKINGRAB -
SPACE F -
CdmoGen -
CMES -
SeaWith -
ARUM THERAPEUTICS -
IDIENCE -
iN Therapeutics -
ANTEROGEN -
ALDAVER -
SNVIA -
SL Therapeutics -
ATsense -
FNCTBIOTECH -
NRISE -
ELGEN THERAPEUTICS -
MxT Biotech -
MTHERA PHARMA -
ONNURISTORE -
Opticho -
Y-Biologics -
Ubix Therapeutics -
IntoCell -
Illimis Therapeutics -
JD Bioscience -
Gencellmed -
GI Cell -
G2E -
G2GBIO -
CHARMACIST -
Kanaph Therapeutics -
CasCure Therapeutics -
CARENATION -
KCell Biosciences -
Curaum -
ClavisTherapeutics -
KEYPRIME Research -
Therapex -
Tomocube -
Txinno Bioscience -
T&R Biofab -
TNS -
Pantilogos -
Phantomics -
Protium Science -
HysensBio -
Huons Meditech -
HUINNO -
Catalog Technologies -
Celloram -
GenEdit -
Hyperfine Research -
PhAST -
Ranelagh
DAYLI PARTNERS
201, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea
Tel : +82-2-563-0890
Fax : +82-2-563-8787
E-mail : contact@dayli.partners
Copyright © 2024 DAYLI PARTNERS. ALL RIGHTS RESERVED